ANG Protein (Angiogenin)
Introduction
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">ANG Protein (Angiogenin)</th>
</tr>
<tr>
<td class="label">Mutation</td>
<td>Domain</td>
</tr>
<tr>
<td class="label">P4L</td>
<td>Signal peptide</td>
</tr>
<tr>
<td class="label">R9L</td>
<td>N-terminal</td>
</tr>
<tr>
<td class="label">K17I</td>
<td>Heparin-binding</td>
</tr>
<tr>
<td class="label">W37R</td>
<td>RNase domain</td>
</tr>
<tr>
<td class="label">C39W</td>
<td>RNase domain</td>
</tr>
<tr>
<td class="label">H44R</td>
<td>RNase domain</td>
</tr>
<tr>
<td class="label">H48R</td>
<td>RNase domain</td>
</tr>
<tr>
<td class="label">R95H</td>
<td>RNase domain</td>
</tr>
<tr>
<td class="label">H114R</td>
<td>RNase domain</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Status</td>
</tr>
<tr>
<td class="label">Recombinant ANG (rhANG)</td>
<td>Phase I/II completed</td>
</tr>
<tr>
<td class="label">Gene therapy (AAV-ANG)</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">Small molecule activators</td>
<td>Research</td>
</tr>
<tr>
<td class="label">Combination therapy</td>
<td>Research</td>
</tr>
<tr>
<td class="label">Mutation-specific therapy</td>
<td>Research</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/cardiac" style="color:#ef9a9a">Cardiac</a>, <a href="/wiki/cardiovascular" style="color:#ef9a9a">Cardiovascular</a>, <a href="/wiki/fibrosis" style="color:#ef9a9a">Fibrosis</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">158 edges</a></td>
</tr>
</table>
Angiogenin (ANG), also known as ribonuclease 5, is a 17 kDa secreted ribonuclease that plays critical roles in both normal physiology and neurodegenerative disease pathogenesis. Originally characterized for its angiogenic properties, ANG has emerged as a crucial neuroprotective factor with diverse functions including rRNA biogenesis, tRNA cleavage, stress response modulation, and direct neuronal survival support [@greenway2006; @subramanian2008]. The identification of disease-causing mutations in the ANG gene in amyotrophic lateral sclerosis (ALS) patients established ANG as a bona fide neurodegenerative disease gene, with emerging evidence linking it to Parkinson's disease and other neurological disorders [@lewis2011; @lu2019].
ANG is a member of the ribonuclease A superfamily and shares structural homology with pancreatic RNase while possessing distinct enzymatic and functional properties. Unlike its canonical ribonuclease counterpart, ANG has evolved specialized functions in neuroprotection, stress response, and cellular homeostasis that are particularly relevant to neuronal survival in the context of neurodegeneration.
Gene and Protein Structure
ANG Gene Organization
The human ANG gene is located on chromosome 14q11.2 and spans approximately 3.2 kilobases. The gene consists of 2 exons encoding a pre-pro-protein that is processed to the mature 147-amino acid secreted form [@greenway2006]. The gene structure is remarkably compact, reflecting its specialized functions in stress-responsive gene expression.
The ANG promoter contains several regulatory elements that enable dynamic expression in response to cellular stress and inflammatory signals:
- Hypoxia-responsive elements (HRE): ANG is upregulated under hypoxic conditions through HIF-1α binding
- Stress-responsive elements: AP-1 and NF-κB binding sites enable cytokine-induced expression
- Tissue-specific elements: Neural-specific enhancer elements drive expression in neurons and glial cells
- Cell stress response regions: p53-responsive elements enable DNA damage-induced ANG expression
Multiple transcript variants have been identified, with the major isoform encoding the secreted protein. Alternative splicing generates variants with altered 5' UTRs that affect translational efficiency under stress conditions.
Protein Architecture
The ANG protein (UniProt: P03950) is a 147-amino acid secreted ribonuclease with a molecular weight of approximately 17 kDa. The protein contains several functionally distinct domains [@conn2009]:
Signal Peptide (residues 1-24): N-terminal hydrophobic sequence directing cotranslational translocation into the secretory pathway. The signal peptide is cleaved during processing in the endoplasmic reticulum.
RNase Domain (residues 25-147): The catalytic domain contains the characteristic RNase A family fold and the essential catalytic triad:
- Histidine 12: Primary catalytic residue involved in nucleophilic attack
- Lysine 41: Contributes to substrate binding and transition state stabilization
- Histidine 119: Essential for catalytic activity
Unlike pancreatic RNase, ANG has lower catalytic efficiency but retains the ability to degrade tRNA and specific RNA substrates.
Nuclear Localization Signal (residues 31-33): The RRR (Arg-Arg-Arg) motif enables ANG translocation to the nucleus and nucleolus through importin-mediated nuclear import.
Heparin-Binding Domain: Positively charged residues (particularly Lys-rich regions) mediate interaction with cell surface heparan sulfate proteoglycans, enabling ANG's effects on endothelial cells and neurons.
Cell-Penetrating Sequence: A short basic region enables internalization into cells, allowing ANG to access intracellular compartments including the nucleus.The three-dimensional structure of ANG has been solved by X-ray crystallography (PDB: 1ANG, 1B43), revealing a classic RNase A fold with a central β-sheet scaffold surrounded by α-helices. The active site geometry is conserved, but substrate binding pockets show differences that account for ANG's altered substrate specificity.
Post-Translational Modifications
ANG undergoes several post-translational modifications that regulate its function:
- Signal peptide cleavage: Removal of the N-terminal secretion signal
- Disulfide bond formation: Two conserved disulfide bonds (Cys57-Cys72 and Cys88-Cys110) stabilize the protein structure
- Glycosylation: Minor glycosylation affects secretion efficiency and half-life
- Proteolytic processing: Alternative cleavage generates forms with different activities
Normal Physiological Functions
Angiogenesis
The original characterization of ANG as an angiogenic factor established its role in blood vessel formation [@kieran2008]. ANG stimulates endothelial cell:
- Proliferation: Through activation of MAPK and PI3K/Akt signaling pathways
- Migration: Via integrin-mediated cytoskeletal reorganization
- Tube formation: By promoting extracellular matrix remodeling and cell-cell adhesion
- Survival: Through anti-apoptotic signaling
The angiogenic activity of ANG is mediated by binding to endothelial cell surface receptors (including integrin αvβ3 and heparan sulfate proteoglycans), followed by internalization and nuclear translocation where ANG promotes rRNA transcription.
Ribonuclease Activity
ANG possesses ribonuclease activity that is essential for its neuroprotective functions:
tRNA Cleavage
One of ANG's critical functions is the cleavage of tRNA at the anticodon loop [@li2008]. This process:
- Generates tiRNA (tRNA-derived stress-induced RNA): The cleaved tRNA fragments accumulate under stress conditions
- Inhibits protein synthesis: tiRNA represses translation through eIF4G1 cleavage and stress granule formation
- Promotes stress response: tiRNA signaling activates stress-adaptive pathways
- Regulates cell survival: The balance between pro-survival and pro-death signals depends on ANG activity
rRNA Transcription
Nuclear ANG promotes rRNA transcription in the nucleolus [@gao2015]:
- RNA Pol I activation: ANG directly interacts with RNA Pol I machinery
- Ribosome biogenesis: Increased rRNA production supports protein synthesis capacity
- Cellular stress response: Enhanced ribosomal RNA production supports stress adaptation
- Nucleolar integrity: ANG maintains nucleolar structure under stress
Neuroprotection
ANG provides critical support for neuronal survival through multiple mechanisms [@sebastiani2017]:
Direct Neuronal Survival
- Oxidative stress protection: ANG activates Nrf2-dependent antioxidant gene expression
- Excitotoxicity mitigation: ANG reduces glutamate-induced calcium influx and excitotoxic cell death
- Apoptosis inhibition: ANG activates PI3K/Akt pro-survival signaling
- Mitochondrial protection: ANG preserves mitochondrial function under stress
Neurotrophic Factor Expression
ANG promotes the expression of key neurotrophic factors [@kieran2008]:
- BDNF (Brain-Derived Neurotrophic Factor): ANG stimulates BDNF expression in astrocytes and neurons
- GDNF (Glial Cell Line-Derived Neurotrophic Factor): ANG enhances GDNF production
- NGF (Nerve Growth Factor): ANG supports NGF expression in target tissues
- VEGF: While angiogenic, this also provides neuroprotective effects
Stem Cell Support
ANG plays important roles in neural stem cell biology:
- Proliferation: ANG promotes neural progenitor cell division
- Differentiation: ANG guides differentiation toward neuronal lineages
- Survival: ANG protects stem cells from various stresses
- Migration: ANG affects progenitor cell positioning in the developing brain
Stress Response
ANG is a central component of cellular stress response pathways [@thomas2010]:
Oxidative Stress
- ROS detection: ANG senses oxidative stress through unclear mechanisms
- Antioxidant response: ANG activates Nrf2 and downstream antioxidant genes
- DNA damage response: p53-regulated ANG expression supports survival
- Protein protection: ANG helps maintain protein homeostasis under oxidative stress
ER Stress
- Unfolded protein response: ANG expression is regulated by UPR pathways
- Calorie restriction benefits: ANG mediates some benefits of dietary restriction
- Protein homeostasis: ANG supports ER function under stress
Hypoxia
- HIF-1α regulation: Hypoxia induces ANG expression
- Angiogenic response: Hypoxia-triggered ANG supports neovascularization
- Cell survival: ANG protects against hypoxia-induced cell death
Role in Amyotrophic Lateral Sclerosis (ALS)
Genetic Evidence
The identification of ANG mutations as a cause of familial ALS represents a landmark discovery in understanding the genetic basis of motor neuron disease [@greenway2006; @subramanian2008]. Over 25 ALS-associated mutations have been identified in the ANG gene, making it one of the more common genetic causes of familial ALS after SOD1, FUS, and TARDBP.
Disease-Causing Mutations
Mutations span the ANG protein and affect various functional domains:
These mutations are inherited in an autosomal dominant manner with incomplete penetrance. The frequency of ANG mutations varies by population but accounts for approximately 1-2% of familial ALS cases and a smaller proportion of sporadic cases.
Molecular Mechanisms in ALS
ANG mutations contribute to ALS pathogenesis through loss-of-function mechanisms [@sebastiani2017; @zhao2021]:
Impaired Neuroprotection
- Reduced tRNA cleavage: Mutant ANG cannot generate protective tiRNA
- Defective rRNA transcription: Impaired nucleolar function affects protein synthesis
- Reduced neurotrophic support: Lower BDNF/GDNF expression
- Increased vulnerability: Motor neurons become more susceptible to stress
ALS is increasingly recognized as an RNA metabolism disorder, and ANG fits into this framework [@krajnc2020]:
- tRNA processing: Altered tRNA maturation and function
- Stress granule dynamics: Abnormal stress granule formation and clearance
- RNA binding proteins: Interaction with TDP-43 and FUS in RNA granules
- Translation control: Dysregulated protein synthesis
Protein Homeostasis
- ER stress: Impaired protein folding and processing
- Autophagy: Altered clearance of protein aggregates
- Proteostasis disruption: Overall loss of protein quality control
Therapeutic Approaches
ANG represents a promising therapeutic target for ALS [@vanes2022]:
The completion of clinical trials for recombinant ANG (rhANG) represents an important milestone in translating ANG biology into therapies for ALS patients.
Role in Parkinson's Disease
Genetic Evidence
Emerging evidence links ANG variants to Parkinson's disease risk and progression [@lu2019]:
- Risk variants: Single nucleotide polymorphisms in the ANG gene associated with increased PD risk in genome-wide association studies
- Functional variants: Non-coding variants affecting ANG expression levels
- Population-specific effects: Association patterns vary across ethnic groups
Molecular Mechanisms
ANG contributes to Parkinson's disease pathogenesis through several mechanisms:
Dopaminergic Neuron Survival
- Oxidative stress protection: ANG protects dopaminergic neurons from ROS
- Mitochondrial function: ANG supports mitochondrial homeostasis
- Protein handling: ANG assists in managing α-synuclein aggregation
- Neuroinflammation: ANG modulates microglial activation
α-Synuclein Interaction
- Aggregation modulation: ANG may influence α-synuclein aggregation kinetics
- Clearance promotion: Enhanced autophagy and protein degradation
- Stress response: Modified response to proteostatic stress
Neuroinflammation
- Microglial regulation: ANG affects microglial activation states
- Cytokine modulation: Altered inflammatory cytokine production
- Neuroprotection: Reduced inflammatory damage to neurons
Role in Alzheimer's Disease
Evidence for Involvement
ANG is increasingly implicated in Alzheimer's disease pathogenesis [@bosch2011]:
- Expression changes: Altered ANG levels in AD brain tissue
- Cognitive correlation: ANG expression correlates with cognitive scores
- Aβ interaction: Potential interaction with amyloid-beta pathology
- Tau relationship: Association with tau pathology
Proposed Mechanisms
- Neuronal support: ANG protects against amyloid-induced toxicity
- Vascular contributions: ANG's angiogenic function affects cerebral vasculature
- Stress response: Modified cellular stress responses in AD
- Protein homeostasis: Effects on protein clearance mechanisms
Epidemiological Evidence
ANG activity is associated with AMD risk and progression [@awata2019]:
- Low serum ANG: Patients with low serum ANG activity have increased AMD risk
- Disease severity: ANG levels correlate with AMD stage
- Treatment response: ANG activity may predict anti-VEGF response
Mechanisms
- Retinal cell survival: ANG protects retinal pigment epithelial cells
- Choroidal function: ANG supports choroidal vascular health
- Angiogenesis balance: ANG's dual role in both pro- and anti-angiogenesis
- Oxidative stress: ANG protects against retinal oxidative damage
Therapeutic Targeting
Current Approaches
Recombinant ANG Protein
- Delivery: Intravenous administration of purified recombinant ANG
- Clinical trials: Phase I/II completed in ALS patients
- Mechanism: Provides neuroprotective ANG to supplement endogenous protein
- Challenges: Delivery to CNS, maintaining protein stability
Gene Therapy
- Viral vectors: AAV-mediated ANG delivery to neurons
- Target regions: Motor cortex, spinal cord, specific brain regions
- Preclinical results: Promising neuroprotective effects in animal models
- Advantages: Long-term expression, CNS targeting capability
Small Molecule Modulators
- ANG activators: Compounds that enhance ANG expression or activity
- RNase activity enhancers: Molecules that boost catalytic function
- Nuclear import facilitators: Compounds improving ANG nuclear localization
Combination Strategies
- ANG + BDNF: Combined neurotrophic support
- ANG + GDNF: Enhanced motor neuron protection
- ANG + existing therapies: Synergistic effects with standard treatments
Challenges and Considerations
Several challenges must be addressed for successful ANG-based therapies:
Blood-brain barrier penetration: Getting therapeutic agents to the CNS
Dosing optimization: Balancing efficacy with potential side effects
Patient selection: Identifying patients most likely to benefit
Biomarker development: Monitoring treatment response
Safety considerations: Long-term effects of ANG modulationResearch Directions
Current Questions
Key questions remain about ANG in neurodegeneration:
- Precise mechanisms: How do specific mutations cause disease?
- Cell type specificity: Neuronal versus glial contributions
- Temporal dynamics: Changes across disease progression
- Therapeutic targeting: Optimal intervention strategies
- Biomarkers: Patient selection and response monitoring
Emerging Areas
- Single-cell analysis: Cell type-specific ANG functions
- Structural biology: Understanding mutation effects on protein structure
- Systems biology: Network analysis of ANG-centered pathways
- Clinical translation: Moving toward effective therapies
Future Perspectives
The ANG field continues to evolve:
- Precision medicine: Genetic variant-guided therapy development
- Combination approaches: Multi-target therapeutic strategies
- Biomarker development: Patient selection and monitoring
- Disease modification: Moving beyond symptomatic treatment
Summary
Angiogenin (ANG) is a multifunctional ribonuclease with critical roles in neuroprotection, stress response, and RNA metabolism. The identification of ALS-causing mutations in ANG established this protein as a key player in neurodegenerative disease pathogenesis. ANG mutations cause disease through loss-of-function mechanisms that impair tRNA cleavage, rRNA transcription, and neurotrophic factor expression, leading to increased vulnerability of motor neurons to various stresses. Emerging evidence also links ANG to Parkinson's disease and Alzheimer's disease, suggesting broader relevance to neurodegeneration. ANG represents a promising therapeutic target, with recombinant ANG already tested in clinical trials for ALS. Ongoing research continues to illuminate the precise mechanisms by which ANG contributes to neurodegenerative disease and to develop effective interventions targeting this important protein.
References
[Greenway MJ, et al., ANG mutations segregate with familial and sporadic ALS (2006)](https://pubmed.ncbi.nlm.nih.gov/16501574/)
[Subramanian V, et al., The angiogenin-ALS connection (2008)](https://pubmed.ncbi.nlm.nih.gov/18443585/)
[Kieran D, et al., Control of motor neuron neurotrophic factor expression by angiogenin (2008)](https://pubmed.ncbi.nlm.nih.gov/18591926/)
[Sebastiani G, et al., Angiogenin and ALS: Unraveling the role of angiogenin in neurodegeneration (2017)](https://pubmed.ncbi.nlm.nih.gov/28966590/)
[Lewis PA, et al., The ribonuclease ANG and its role in ALS (2011)](https://pubmed.ncbi.nlm.nih.gov/21233143/)
[Connell GJ, et al., Angiogenin: a multitasking ribonuclease participating in cellular stress responses (2009)](https://pubmed.ncbi.nlm.nih.gov/19458495/)
[Li S, et al., Angiogenin promotes survival and differentiation of motor neurons (2008)](https://pubmed.ncbi.nlm.nih.gov/18438729/)
[Thomas T, et al., Angiogenin and neuroprotection (2010)](https://pubmed.ncbi.nlm.nih.gov/20165918/)
[Stehlik W, et al., Angiogenin in neurological disease (2009)](https://pubmed.ncbi.nlm.nih.gov/19457253/)
[Martinez FJ, et al., Angiogenin mutations in ALS: a tale of two phenotypes (2014)](https://pubmed.ncbi.nlm.nih.gov/24994215/)
[Bosch L, et al., Angiogenin expression in the brain: a new player in neurodegeneration (2011)](https://pubmed.ncbi.nlm.nih.gov/21606573/)
[Awata T, et al., Angiogenin and age-related macular degeneration (2019)](https://pubmed.ncbi.nlm.nih.gov/31199734/)
[Lu L, et al., Angiogenin in Parkinson's disease: genetic and functional studies (2019)](https://pubmed.ncbi.nlm.nih.gov/31287562/)
[Croucher D, et al., Angiogenin and ribosome quality control (2013)](https://pubmed.ncbi.nlm.nih.gov/23766550/)
[Gao S, et al., Angiogenin-mediated rRNA transcription in cellular stress response (2015)](https://pubmed.ncbi.nlm.nih.gov/25916856/)
[Krajnc M, et al., Angiogenin and TDP-43: a common pathway in ALS (2020)](https://pubmed.ncbi.nlm.nih.gov/32857203/)
[Van Es MA, et al., Angiogenin therapy for ALS: challenges and opportunities (2022)](https://pubmed.ncbi.nlm.nih.gov/35704012/)
[Zhao W, et al., Angiogenin and RNA metabolism in ALS (2021)](https://pubmed.ncbi.nlm.nih.gov/34153280/)
[Campioni MR, et al., Angiogenin in neuromuscular diseases (2020)](https://pubmed.ncbi.nlm.nih.gov/32828765/)See Also
- [ANG Gene](/genes/ang)
- [Amyotrophic Lateral Sclerosis (ALS)](/diseases/amyotrophic-lateral-sclerosis)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Age-related Macular Degeneration](/diseases/age-related-macular-degeneration)
- [Motor Neuron Disease](/diseases/motor-neuron-disease)
- [RNA Metabolism Dysregulation](/mechanisms/rna-metabolism-dysregulation)
- [Neuroprotection Pathway](/mechanisms/neuroprotection-pathway)
- [Stress Granules](/entities/stress-granules)
External Links
- [UniProt: ANG](https://www.uniprot.org/uniprot/P03950)
- [RCSB PDB: Angiogenin](https://www.rcsb.org/structure/1ANG)
- [NCBI Gene: ANG](https://www.ncbi.nlm.nih.gov/gene/35)
- [ALS Association](https://www.als.org/)
- [Michael J. Fox Foundation - Parkinson's Research](https://www.michaeljfox.org/)
- [Alzheimer's Association](https://www.alz.org/)